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MicroRNA Expression in Melanocytic Nevi: The
Usefulness of Formalin-Fixed, Paraffin-Embedded
Material for miRNA Microarray Profiling
Martin Glud1, Mikkel Klausen2, Robert Gniadecki3, Maria Rossing2, Nina Hastrup4, Finn C. Nielsen2 and
Krzysztof T. Drzewiecki1
MicroRNAs (miRNAs) are small, noncoding RNA molecules that regulate cellular differentiation, proliferation,
and apoptosis. MiRNAs are expressed in a developmentally regulated and tissue-specific manner. Aberrant
expression may contribute to pathological processes such as cancer, and miRNA may therefore serve as
biomarkers that may be useful in a clinical environment for diagnosis of various diseases. Most miRNA profiling
studies have used fresh tissue samples. However, in some types of cancer, including malignant melanoma, fresh
material is difficult to obtain from primary tumors, and most surgical specimens are formalin fixed and paraffin
embedded (FFPE). To explore whether FFPE material would be suitable for miRNA profiling in melanocytic
lesions, we compared miRNA expression patterns in FFPE versus fresh frozen samples, obtained from 15 human
melanocytic nevi. Out of microarray data, we identified 84 miRNAs that were expressed in both types of samples
and represented an miRNA profile of melanocytic nevi. Our results showed a high correlation in miRNA
expression (Spearman r-value of 0.80) between paired FFPE and fresh frozen material. The data were further
validated by quantitative RT-PCR. In conclusion, FFPE specimens of melanocytic lesions are suitable as a source
for miRNA microarray profiling.
Journal of Investigative Dermatology (2009) 129, 1219–1224; doi:10.1038/jid.2008.347; published online 13 November 2008
INTRODUCTION
MicroRNAs (miRNAs) are small noncoding, regulatory RNAs,
involved in several fundamental cellular processes such as
differentiation, proliferation, and apoptosis (Ambros, 2004).
MiRNAs exert their function by binding to a subset of target
mRNAs, resulting in translational repression and/or increased
degradation of mRNA. More than 851 human miRNA genes
(miRBAse, Sanger Wellcome Trust Institute) and an even
greater number of predicted targets have been identified in
the human genome (Rajewsky and Socci, 2004). MiRNA
genes are frequently located in chromosomal regions
representing fragile sites, minimal regions of loss of hetero-
zygosity, and minimal regions of amplification indicating that
miRNAs could be a new class of oncogenes (Sevignani
et al., 2006). MiRNA expression is highly tissue-specific
(Landgraf et al., 2007; Rosenfeld et al., 2008) and miRNA-
expression signatures can potentially be used as tumor
biomarkers (Calin and Croce, 2006). Cancer stage and
prognosis have already been correlated to the deregulation
of miRNA-expression and distinct patterns of miRNA profiles
have been associated with different clinical features (Yu
et al., 2007).
Most studies of miRNA-expression patterns in cancer
tissues have been performed on snap-frozen fresh tumor
samples, where RNA is assumed to be well preserved.
However, use of formalin-fixed, paraffin-embedded (FFPE)
tissue samples is preferable because archival material is
readily available and may be correlated to clinical data. Only
few studies have used human FFPE tissue samples for miRNA
profiling studies (Li et al., 2007; Tetzlaff et al., 2007; Wang
et al., 2007; Xi et al., 2007; Chen et al., 2008; Rosenfeld
et al., 2008). The major difficulty is that RNA molecules are
degraded and chemically modified by methylol groups
during formalin fixation (Doleshal et al., 2008). Additional
variability is introduced by different fixation times. However,
some studies have revealed that miRNAs apparently are
unaffected and well preserved in FFPE tissues. In mouse liver,
expression of miRNA was not significantly affected by
formalin fixation for up to 5 days (Xi et al., 2007). Two
studies have moreover demonstrated high correlation in
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global miRNA expression between fresh frozen and FFPE
human cancer samples using microarray platforms (Wang
et al., 2007; Xi et al., 2007; Rosenfeld et al., 2008) or stem-
loop RT-PCR quantification techniques in a cell line model
(Li et al., 2007).
Malignant melanoma is a potentially deadly skin tumor
and its incidence is constantly rising. A key barrier in genetic
characterization of melanoma is to obtain a sufficient amount
of fresh tissue sample from primary tumor. According to the
therapeutic guidelines in most countries, the whole primary
tumor should be microscoped for the determination of tumor
thickness. Development of techniques that utilize paraffin-
embedded samples would be a significant step forward, and
allow studies on the vast quantities of readily available
archival samples. To explore the usefulness of paraffin-
embedded material for miRNA studies, we compared
miRNA-expression profiles from paraffin-embedded melano-
cytic nevi with those of frozen melanocytic nevi. The results
show that high-quality miRNA can be extracted from FFPE
nevi and that reproducible and comparable miRNA-expres-
sion profiles can be obtained from FFPE and fresh frozen
samples.
RESULTS
Extraction of miRNA from FFPE and fresh frozen tissue
To determine the yield and quality of miRNA in fresh versus
FFPE-fixed material, surgically removed benign nevi were cut
into two halves. One part was instantly immersed in TRIzol
and frozen at 80 1C, whereas the other part was fixed in
formalin and embedded in paraffin for standard histopatho-
logic examination. The concentration of small RNA (includ-
ing miRNA), extracted from both FFPE and frozen tissue was
measured using a NanoDrop ND-1000 Spectrophotometer.
For all samples, the total yield of small RNA was larger in
frozen tissue compared to FFPE (Table S1). This was
expected, as starting amount of frozen tissue exceeded that
of FFPE, where histological sections were used as a source.
We measured the integrity, size, and concentration of miRNA
by capillary electrophoresis in all samples. The elution
profiles of small RNAs were in general sharper in frozen
tissue compared to the smoother peaks in the FFPE counter-
parts (Figure 1), indicating a mild RNA degradation by
formalin fixation. MiRNAs elute in the range of 20–40 nt.
Peaks at 60–80 and 100–120nt corresponding tRNA and
5 seconds RNA, respectively, were typically observed in both
types of samples. Thus, we were able to identify low-quality
RNA samples, before miRNA labeling and hybridization by
examining the integrity of the RNA signal.
MicroRNA-expression in frozen versus FFPE tissue
To determine the correlation between miRNA-expression
profiles from FFPE samples with frozen samples, we compared
the miRNA-expression profiles of 15 human nevi using a dual-
color system. Each microarray was loaded with extracted
miRNA from the FFPE and the corresponding fresh frozen
sample. After hybridization, scanning, and analyzing of the
resulting image, the data were normalized, and the scatterplots
were generated to visualize correlation between the different
preservation methods (Figure 2). In general, there was good
correlation between miRNA-expression profiles in FFPE nevus
fragment compared to the fresh frozen part, as the Spearman
r-coefficient ranged from 0.72 to 0.94. For the joint samples,
the r-value was 0.80 (Figure 3). In our study, 84 different
miRNAs were expressed in all samples (Table S2) and a heat
map of expressed miRNAs in our melanocytic lesions showed
a systematic pattern (Figure 4). In general, there were good
concordance between the miRNA profiles of the fresh samples
and the FFPE samples, although few miRNA showed markedly
differences in expression values. Figure 5 shows the differences
between expression of all miRNAs documenting that only two
miRNAs (miR-768-5p, miR-494) had an increased expression
in FFPE samples compared to the fresh ones, and two miRNAs
(miR-320, miR-19b) had a decreased expression, using the
accepted cutoff value off log2 of 1.0.
Validation by qRT-PCR
Quantitative RT-PCR was used to validate the levels of
expressions on a subset of miRNAs using three of the original
samples (representative). Three highly expressed miRNAs
(Let-7a, miR-24, and miR-203) and three miRNAs in the
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Figure 1. Electropherograms of small RNA extracted and enriched from frozen and FFPE tissue respectively. Enriched miRNA was loaded on a Bioanalyzer
small RNA Chip and fractionated in an Agilent 2100 Bioanalyzer. The miRNA region is defined by the vertical borders, peaks representing tRNA and 5S RNA are
marked accordingly.
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lower end (miR-34a, miR-195, and miR-25) were chosen for
validation of expression levels. The results confirmed the
expression distribution obtained by microarray techniques
(Table S3).
DISCUSSION
The functional relevance of the identified miRNA species in
nevi is challenging and remains to be determined by direct
experimental evidence. A recent review paper proposed a
way to determine miRNA targets by combination of three
different computational programs (MiRanda, TargetScan, and
PicTar; Kuhn et al., 2008). It would be of obvious interesting
to determine whether miRNAs found in melanocytic nevi
have targets in the genes known to be involved in the
development of malignant melanoma. Nevi are considered as
premalignant precursor lesions where the cells are mitotically
arrested in a senescence-like state, but harbor the potentially
deleterious mutations. Mutations in the oncogenes along the
BRAF/N-Ras pathway and tumor suppressor genes CDKN2A
and PTEN are considered significant. These genes have
predicted binding sites for many miRNAs, including let-7
family, miR-24, miR-26a, miR-29a, and miR-125b, all of
which were expressed in our samples (Table S2). Although
these findings are intriguing, the functional relevance of
miRNA species should be experimentally confirmed.
For decades, most surgical specimens have been formalin
fixed and paraffin embedded, resulting in large numbers of
archived FFPE tissue samples. With the recent advent of
miRNAs and their clinical usefulness as biomarkers, the
development of techniques to retrieve the material from FFPE
material is a matter of priority. We examined the utility of
FFPE human melanocytic nevi, which were considered to
represent a tissue closely related to melanoma. By compar-
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Figure 2. Scatterplots of each individual sample showing miRNA expression (log10) of paired FFPE and fresh frozen melanocytic. Correlation analysis of each
sample showed Spearman r-values in a range of 0.72–0.94. Horizontal axes are FFPE samples, vertical axes are paired fresh frozen samples.
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ison of miRNA-expression profiles of corresponding fresh
frozen and FFPE samples, using microarray techniques, we
demonstrate that there is a good correlation (Spearman’s
coefficient in the range of 0.72–0.94) between miRNA
profiles of melanocytic nevi. Our results were further
validated by qRT-PCR, indicating that FFPE samples are
suitable for miRNA profiling studies.
In conclusion, the ability to use FFPE nevi samples for
miRNA-expression studies opens venue for the investigation
of the importance of miRNA in malignant melanoma. To
secure a true expression signature, further methods should be
designed to eliminate a contamination of samples by
nontumor cells, for example stromal cells, by laser capture
microdissection.
MATERIALS AND METHODS
Patients and sample preparations
All studies were carried out in adherence to the Declaration of
Helsinki Principles and were approved by the Danish National
Committee on Biomedical Research Ethics. After written, informed
consent, 15 patients were recruited at Department of Dermatology,
University of Copenhagen, Faculty of Health Sciences; Bispebjerg
Hospital, Copenhagen, Denmark. We included 15 patients (8
women and 7 men, between 19 and 48 years of ages) with clinically
benign nevi who requested a surgical excision of a nevus for
cosmetic reasons. After excision, tissue samples were quickly
divided into two pieces, and the one piece was immediately placed
in TRIzol (Invitrogen, Carlsbad, CA) and kept frozen at 80 degrees,
and the other half was fixed in formalin and paraffin embedded using
standard method of Department of Pathology, University of
Copenhagen. The clinical diagnoses of a benign nevus were
confirmed by histopathological examination in all cases, given six
dermal nevi and nine compound nevi.
MicroRNA isolation
The frozen samples were homogenized in TRIzol (Invitrogen), using
a tissue homogenizer (TissueLyser, Qiagen GmbH, Germany).
Isolation of miRNA was carried out using PureLink miRNA Isolating
Kit (Invitrogen) according to the manufacturer’s instructions. Briefly,
miRNA was extracted from tissue lysate through ethanol-dependent
selective binding to column membranes and finally eluted in RNase-
free water. For RNA extraction from FFPE samples, 10 sections
(thickness 20 mm) were cut on a microtome and melted in a specially
designed melting buffer (Invitrogen) at 72 1C for 10minutes.
Following a modified protocol of PureLink FFPE total RNA isolation
kit (Invitrogen), the tissue was further digested by proteinase K and
Figure 4. Heat map of expressed miRNA in melanocytic nevi. Tissue samples
are displayed on the vertical axis. The columns represent one sample
separated as either fresh frozen (columns 1–16) or FFPE (17–32). Horizontal
axis represents individual miRNAs. Red color symbolizes expression of a
miRNA in the sample.
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Figure 3. Scatterplot showing miRNA expression (log10) of paired FFPE and
fresh frozen melanocytic nevi. All samples are merged. Correlation analysis
of merged miRNA resulted in a Spearman r-value of 0.8.
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incubated in 3 hours at 63 1C. Next, the tissue was separated
from the melted paraffin by centrifugation at top speed (16,000 g)
for 1minute. The resulting lysate was transferred to Spin
Cartridges in collection tubes, filtered, washed, and finally eluted
in RNase-free water to further downstream applications. The final
miRNA concentrations of samples were measured using a
NanoDrop ND-1000 Spectrophotometer (Wilmington, USA). RNA
quality was measured using Agilent Small RNA Kit with an
Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn,
Germany).
Microarray platform
MiRNA samples were labeled using Invitrogen NCode Rapid miRNA
Labelling System, according to the manufacturer’s instructions. This
system directly labels the miRNAs with fluorescent Alexa Fluor dyes.
Labeled samples were hybridized overnight to Invitrogen NCode
Multi-Species miRNA Microarrays (version V2), which contain
probes for 553 human miRNA cataloged in the miRBase Sequence
Database (Release 9.0 (Http://microrna.sanger.ac.uk/).
Image analysis
After hybridization, slides were scanned using an Agilent DNA
Microarray Scanner and the resulting images analyzed using the
GenePix Pro 6.0. All artifactual spots were eliminated manually.
Image intensities were measured as median of foreground intensities,
and background correction was performed during statistical analysis,
as were normalization.
Statistics
Intensity data were analyzed using CARMAweb 1.4, an R- and
Bioconductor-based web service for microarray data analysis (Rainer
et al., 2006). Raw data gpr-files were background corrected by the
normexp method (Ritchie et al., 2007). The data were normalized
within each array using Print-tip Loess normalization and between
the chips using Aquantile normalization (Smyth and Speed, 2003).
Normalized data were used to determine Spearman’s correlation
values between FFPE and fresh frozen samples using GraphPad
Prism 4 (GraphPad Software Inc., USA). Microsoft Excel 2000
(Microsoft Corporation, USA) was used to produce M (log red/green)
value plot.
qRT-PCR
cDNA was prepared from miRNA samples using TaqMan MicroRNA
Reverse Transcription Kit on the Applied Biosystems 7900 HT Fast
Real-Time PCR System according to the manufacturer’s instructions
(Applied Biosystems, Foster City, CA, USA). Predesigned TaqMan
MicroRNA Assays for hsa-let-7a, hsa-miR-24, hsa-miR-25, hsa-
miR34a, hsa-miR-195, hsa-miR-203, and control RNU6B were
purchased from Applied Biosystems. qPCR was performed using
TaqMan Universal PCR Master Mix, according to the manufacturer’s
protocol (Applied Biosystems).
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SUPPLEMENTARY MATERIAL
Table S1. Nevi data: Concentration and total yield after extraction of miRNA
measuered by NanoDrop.
Table S2. MiRNA-expression profile of melanocytic nevi, represented by 84
different miRNAs listed in decreasing frequency.
Table S3. Raw Ct values of highly expressed miRNAs (let-7a, miR-25, and
miR-24) and poorly expressed (miR-195, miR-203, and miR34a).
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Figure 5. Sorted log2 expression levels of miRNAs with decreased expression and increased expression in FFPE compared to fresh frozen tissues.MiRNAs with
expression differences above 1.00 or below 1.00 are marked red.
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